SplitNov 4, 2026, 06:31 AM
Bluejay Diagnostics Completes 1-for-4 Reverse Stock Split
AI Summary
Bluejay Diagnostics, Inc. announced the effectiveness of its 1-for-4 reverse stock split on November 3, 2026. This action, approved by the Board of Directors and stockholders, reduced the number of outstanding common shares from approximately 4.47 million to 1.12 million. The par value and voting rights remain unchanged. Fractional shares were settled with cash payments, and adjustments were made to outstanding equity awards and warrants.
Key Highlights
- Bluejay Diagnostics implemented a 1-for-4 reverse stock split effective November 3, 2026.
- The split reduced outstanding shares from 4,468,051 to approximately 1,117,013.
- The par value of common stock remained $0.0001 per share.
- No fractional shares were issued; cash payments were made in lieu of fractional shares.
- Equity awards and warrants were proportionally adjusted in number and exercise price.
Price Impact
More from BJDX